Episode Details

Pertussis (Whooping Cough) is a highly contagious, acute respiratory disease caused by the bacterium Bordetella pertussis. It is primarily a toxin-mediated disease where bacteria attach to respiratory cilia, paralyzing them and causing inflammation that hinders the clearing of secretions. While it affects all ages, it is most dangerous for infants, potentially leading to apnea (pauses in breathing), pneumonia, and death.

The Three Clinical Stages

The hallmark of Pertussis is its progression through three distinct stages over several weeks or months:

• 1. Catarrhal Stage (1–2 weeks): This is the most infectious phase. Symptoms resemble a common cold—runny nose, low-grade fever, and mild cough. Because symptoms are nonspecific, diagnosis is often missed here, facilitating spread.

• 2. Paroxysmal Stage (1–6+ weeks): The cough becomes severe, occurring in rapid bursts (paroxysms) due to thick mucus.

◦ The "Whoop": A long inspiratory effort following a coughing fit often creates a high-pitched "whoop".

◦ Post-tussive Vomiting: Vomiting and exhaustion frequently follow coughing spells.

◦ Infant Presentation: Infants <6 months often lack the strength to "whoop." Instead, they may present with apnea (cessation of breathing), cyanosis, or gagging.

• 3. Convalescent Stage (Weeks to months): Recovery is gradual. Coughing lessens but paroxysms can recur with subsequent respiratory infections.

Transmission and Epidemiology

• Highly Contagious: Transmission occurs via respiratory droplets. Secondary attack rates in households can reach 80%.

• Reservoirs: Humans are the only reservoir. Adults and adolescents with milder disease (often asymptomatic or just a persistent cough) are frequently the source of infection for infants.

• Resurgence: despite vaccination, cases have increased in the U.S. since the 1980s. This is attributed to better reporting, diagnostic changes, and waning immunity from newer acellular vaccines.

Diagnosis and Treatment

• Diagnosis: Polymerase Chain Reaction (PCR) is the preferred rapid test, most sensitive in the first 3 weeks of cough. Culture is the gold standard but difficult to perform.

• Antibiotics: Macrolides (azithromycin, clarithromycin) are the treatment of choice.

◦ Timing is Key: Antibiotics eradicate the bacteria and stop transmission. They only modify the course of illness if started early (catarrhal stage). If started during the paroxysmal stage, they prevent spread to others but do not reduce symptoms.

• Management: Treatment is largely supportive (hydration, oxygen). Hospitalization is often required for young infants for monitoring of apnea.

Prevention and Vaccination

Vaccination is the primary preventive strategy, though immunity is not permanent.

• DTaP: Administered to children under 7 years (2, 4, 6, 15-18 months, and 4-6 years).

• Tdap: A booster for adolescents (11-12 years) and adults. Pregnant women should receive Tdap during every pregnancy to pass antibodies to the fetus.

• Post-Exposure: All close contacts of a case should receive antibiotics regardless of vaccination status to prevent transmission